| Early transfusIon of Convalescent Plasma in Elderly COVID-19 Patients. to Prevent Disease Progression. (NCT04374526) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2020-05-27 |
| Efficacy and Safety of HVA Regimens as Salvage Treatment in rrAML (NCT04424147) | Nanfang Hospital, Southern Medical University | 2020-05-27 |
| Study of Radspherin® in Colorectal Carcinoma Subjects With Peritoneal Carcinomatosis Treated With HIPEC (NCT03732781) | Oncoinvent Solutions AS | 2020-05-27 |
| Evaluate the Safety and Efficacy of Botulax® in Subjects With Benign Masseteric Hypertrophy (NCT04443244) | Hugel | 2020-05-27 |
| Clinical Trial Using Humanized CART Directed Against BCMA (ARI0002h) in Patients With Relapsed/Refractory Multiple Myeloma to Proteasome Inhibitors, Immunomodulators and Anti-CD38 Antibody. (NCT04309981) | Sara V. Latorre | 2020-05-27 |
| UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma (NCT04382664) | Ultimovacs ASA | 2020-05-27 |
| CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients (NCT04195945) | Fred Hutchinson Cancer Center | 2020-05-27 |
| Colchicine in Patients With Mild and Severe Coronavirus Disease (NCT04367168) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2020-05-27 |
| Liposomal Cytarabine and Daunorubicin (CPX-351) and Quizartinib for the Treatment of Acute Myeloid Leukemia and High Risk Myelodysplastic Syndrome (NCT04128748) | M.D. Anderson Cancer Center | 2020-05-27 |
| A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy (NCT04096560) | Takeda | 2020-05-27 |
| Avatrombopag for Thrombocytopenia in People With Cancer (NCT04437953) | Memorial Sloan Kettering Cancer Center | 2020-05-27 |
| Effect of Hemp-CBD on Patients With CIPN (NCT04398446) | Main Line Health | 2020-05-27 |
| Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma (NCT04150562) | National Cancer Institute (NCI) | 2020-05-26 |
| Anticancer Therapeutic Vaccination Using Telomerase-derived Universal Cancer Peptides in Glioblastoma (NCT04280848) | Centre Hospitalier Universitaire de Besancon | 2020-05-26 |
| Zanubrutinib and Rituximab for the Treatment of Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT04458610) | M.D. Anderson Cancer Center | 2020-05-26 |
| The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19 (NCT04347915) | Bukwang Pharmaceutical | 2020-05-26 |
| INFORM2 Study Uses Nivolumab and Entinostat in Children and Adolescents With High-risk Refractory Malignancies (NCT03838042) | University Hospital Heidelberg | 2020-05-26 |
| Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer (NCT04093167) | Canadian Cancer Trials Group | 2020-05-26 |
| Lutetium-177-PSMA Radioligand Therapy in Advanced Salivary Gland Cancer Patients (NCT04291300) | Radboud University Medical Center | 2020-05-26 |
| Safety and Efficacy of AT-527 in Subjects With Moderate Coronavirus Disease (COVID-19) in a Hospital Setting (NCT04396106) | Atea Pharmaceuticals, Inc. | 2020-05-26 |
| A Study of the Oral Farnesoid X Receptor Modulator EYP001a to Assess Its Safety and Anti-viral Effect in Chronic Hepatitis B Patients in Combination With Pegylated Interferon alpha2a Alone and With Entecavir (NCT04365933) | Enyo Pharma | 2020-05-25 |
| Evaluation of the Safety and Immunogenicity of a SARS-CoV-2 rS Nanoparticle Vaccine With/Without Matrix-M Adjuvant (NCT04368988) | Novavax | 2020-05-25 |
| Dornase Alpha for the Treatment of COVID-19 (NCT04432987) | Acibadem University | 2020-05-25 |
| DS-8201a for trEatment of aBc, BRain Mets, And Her2[+] Disease (NCT04420598) | MedSIR | 2020-05-25 |
| Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer (NCT04257448) | GWT-TUD GmbH | 2020-05-25 |
| Total Neoadjuvant Treatment Plus SHR1210 for High-risk Rectal Cancer and Biomarker Screening Base on Neoantigen (NCT04340401) | Peking University Cancer Hospital & Institute | 2020-05-25 |
| Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer (NCT04354662) | Tianjin Medical University Cancer Institute and Hospital | 2020-05-25 |
| Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901 (NCT04396457) | National Hospital Organization Nagoya Medical Center | 2020-05-25 |
| Inhaled Iloprost for Suspected COVID-19 Respiratory Failure (NCT04445246) | Hamad Medical Corporation | 2020-05-23 |
| A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine (NCT05694728) | Beijing Health Guard Biotechnology, Inc | 2020-05-23 |
| Pyrotinib Plus Vinorelbine in Participants With HER2-positive Previously Treated Locally Advanced or Metastatic Breast Cancer (NCT04605575) | Sun Yat-sen University | 2020-05-22 |
| Enoxaparin in COVID-19 Moderate to Severe Hospitalized Patients (NCT04427098) | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2020-05-22 |
| Anlotinib and Niraparib Dual Therapy Evaluation in Platinum-resistant Recurrent Ovarian Cancer (NCT04376073) | Jihong Liu | 2020-05-22 |
| Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants (NCT04398706) | Sanofi Pasteur, a Sanofi Company | 2020-05-22 |
| Nivolumab Maintenance in Newly Diagnosed PCNSL With Persistent CSF Circulating Tumor DNA After Completion of First-Line Chemotherapy (NCT04401774) | Memorial Sloan Kettering Cancer Center | 2020-05-22 |
| Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19) (NCT04397497) | Ospedale San Raffaele | 2020-05-22 |
| PRE-VENT Study in Hospitalized Patients With Severe COVID-19 With or Without Cancer (NCT04404361) | CTI BioPharma | 2020-05-22 |
| Adjuvant Treatment With Cisplatin-based Chemotherapy Plus Concomitant Atezolizumab in Patients With Stage I (Tumors ≥ 4cm), IIA, IIB, and Select Stage III [Any T1-3 N1-2 and T4N0-2] Resected Non-small Cell Lung Cancer (NSCLC) and the Clearance of Circulating Tumor DNA (ctDNA) (NCT04367311) | Nasser Hanna | 2020-05-22 |
| Altered Tumor Oxygenation by Metformin, a Potential Step in Overcoming Radiotherapy Resistance in LACC (NCT04275713) | Oslo University Hospital | 2020-05-22 |
| Theophylline for Treatment of Pseudohypoparathyroidism (NCT04240821) | Jaclyn Tamaroff | 2020-05-22 |
| Low Dose Treosulfan Based Conditioning Regimen in HSCT for Nijmegen Breakage Syndrome (NCT04400045) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2020-05-22 |
| Safety and Immunogenicity Study of Inactivated Vaccine for Prevention of SARS-CoV-2 Infection(COVID-19) (NCT04383574) | Sinovac Life Sciences Co., Ltd. | 2020-05-22 |
| Clostridium Histolyticum Collagenase Injection for Urethral Disease (NCT02948842) | University of South Florida | 2020-05-22 |
| Clinical Trial to Evaluate the Effectiveness and Safety of Tocilizumab for Treating Patients With COVID-19 Pneumonia (NCT04445272) | Fundacion SEIMC-GESIDA | 2020-05-22 |
| Zilucoplan® in Improving Oxygenation, Short-, Longterm Outcome of COVID19 Patients With Acute Hypoxic Respiratory Failure (NCT04382755) | University Hospital, Ghent | 2020-05-22 |
| Safety and Efficacy of Autologous Platelet-Rich Plasma for Erectile Dysfunction. (NCT04396795) | University of Miami | 2020-05-21 |
| Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension (NCT04488978) | Handok Inc. | 2020-05-21 |
| Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer (NCT04289779) | Deepak Kilari | 2020-05-21 |
| Induction Chemotherapy Combined With Immunotherapy for Locally Advanced Hypopharyngeal Carcinoma (NCT04156698) | Eye & ENT Hospital of Fudan University | 2020-05-21 |
| Neoadjuvant T-VEC in High Risk Early Melanoma (NCT04427306) | University of California, Davis | 2020-05-21 |
| Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2) (NCT04416984) | Allogene Therapeutics | 2020-05-21 |
| Nigella Sativa in COVID-19 (NCT04401202) | King Abdulaziz University | 2020-05-21 |
| A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study) (NCT04256317) | Taiho Oncology, Inc. | 2020-05-21 |
| Organ Preservation Program Using Short-Course Radiation & FOLFOXIRI in Rectal Cancer (NCT04380337) | Stanford University | 2020-05-21 |
| Efficacy and Safety of Niraparib Combined With Oral Etoposide in Platinum Resistant/Refractory Recurrent Ovarian Cancer (NCT04217798) | Peking Union Medical College Hospital | 2020-05-21 |
| LVN- IUS Versus Oral Megesterol Acetate in Treatment of Atypical Endometrial Hyperplasia (NCT04385667) | Zagazig University | 2020-05-20 |
| Pembrolizumab in Early Stage Colon Cancer (NCT04231526) | University of Chicago | 2020-05-20 |
| Antithrombotic Therapy to Ameliorate Complications of COVID-19 (ATTACC) (NCT04372589) | University of Manitoba | 2020-05-20 |
| Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in Blepharospasm (NCT04423341) | Silkiss Eye Surgery | 2020-05-20 |
| Intravesical Lactobacillus to Reduce Urinary Symptoms After Spinal Cord Injury (NCT04373512) | Medstar Health Research Institute | 2020-05-20 |
| Amiodarone or Verapamil in COVID-19 Hospitalized Patients With Symptoms (NCT04351763) | Nicolaus Copernicus University | 2020-05-20 |
| Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy (NCT04351256) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2020-05-20 |
| Convalescent Plasma Therapy in Severe COVID-19 Infection (NCT04403477) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2020-05-20 |
| Uterine Serous Carcinoma and Adjuvant Combined Intraperitoneal Chemotherapy and Radiation (NCT04030000) | Northwell Health | 2020-05-20 |
| Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant (NCT03774082) | Novartis Pharmaceuticals | 2020-05-20 |
| Defibrotide in COVID-19 Pneumonia (NCT04335201) | IRCCS San Raffaele | 2020-05-20 |
| Convalescent Plasma of Covid-19 to Treat SARS-COV-2 a Randomized Doble Blind 2 Center Trial (NCT04405310) | Grupo Mexicano para el Estudio de la Medicina Intensiva | 2020-05-20 |
| Baricitinib Compared to Standard Therapy in Patients With COVID-19 (NCT04393051) | Azienda Ospedaliero, Universitaria Pisana | 2020-05-20 |
| Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast Cancer (NCT03971045) | European Institute of Oncology | 2020-05-20 |
| Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC) (NCT04676997) | Shandong Cancer Hospital and Institute | 2020-05-20 |
| Neoadjuvant Gemcitabine Plus Cisplatin With or Without Durvalumab in Resectable Biliary Tract Cancer (NCT04308174) | Asan Medical Center | 2020-05-20 |
| A Study of TQ-B3525 in the Treatment of Relapsed / Refractory Follicular Lymphoma (FL) (NCT04324879) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-05-20 |
| Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation (NCT04492514) | Kristin Hudock | 2020-05-20 |
| Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments. (NCT03838744) | Italian Sarcoma Group | 2020-05-20 |
| Exchange Transfusion Versus Plasma From Convalescent Patients With Methylene Blue in Patients With COVID-19 (NCT04376788) | Ain Shams University | 2020-05-20 |
| Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation (NCT04399980) | The Cleveland Clinic | 2020-05-20 |
| Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS) (NCT04383275) | Fudan University | 2020-05-20 |
| Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases (NCT03754140) | Melanoma Institute Australia | 2020-05-20 |
| LONsurf and G-CSF Use: Being On A Right Dose-intensity to Optimize Treatment Efficacy (NCT04166604) | GERCOR - Multidisciplinary Oncology Cooperative Group | 2020-05-20 |
| CONVALESCENT PLASMA FOR ILL PATIENTS BY COVID-19 (NCT04356482) | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | 2020-05-20 |
| A Phase II Study of Carelizumab Combined With Irinotecan and Apatinib of Second-line Treatment for Advanced Gastric Cancer (NCT04934618) | Nanfang Hospital, Southern Medical University | 2020-05-19 |
| Clinical Trial to Evaluate Efficacy and Safety of Dupilumab in Localized Scleroderma (NCT04200755) | University of Cologne | 2020-05-19 |
| Study of Verinurad in Heart Failure With Preserved Ejection Fraction (NCT04327024) | AstraZeneca | 2020-05-19 |
| A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor (NCT04305275) | Sage Therapeutics | 2020-05-19 |
| CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies (NCT04186520) | Medical College of Wisconsin | 2020-05-18 |
| Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM (NCT04176718) | Andrew Yee, MD | 2020-05-18 |
| Effectiveness and Safety of Convalescent Plasma Therapy on COVID-19 Patients With Acute Respiratory Distress Syndrome (NCT04380935) | Indonesia University | 2020-05-18 |
| Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19 (NCT04381884) | Laboratorio Elea Phoenix S.A. | 2020-05-18 |
| GM-CSF With Post-Transplant Cyclophosphamide (NCT04237623) | Northside Hospital, Inc. | 2020-05-18 |
| Nivolumab + Ipilimumab + Radiation in MSS Pancreatic Cancer (NCT04361162) | Massachusetts General Hospital | 2020-05-18 |
| Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma (NCT04586543) | László Mangel | 2020-05-18 |
| Efficacy of Topical Treatment With Clobetasol in Symptomatic Oral Lichen Planus. (NCT04364555) | Malmö University | 2020-05-18 |
| A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) (NCT04004611) | Eli Lilly and Company | 2020-05-18 |
| A Phase II Prospective Trial of mXELOXIRI Reintroduction for mCRC (NCT04508452) | First Affiliated Hospital of Zhejiang University | 2020-05-18 |
| Extracorporal Photopheresis With UVADEX Plus Standard Steroid Treatment for High Risk Acute Graft-versus-host Disease (NCT04291261) | Universitätsklinikum Hamburg-Eppendorf | 2020-05-18 |
| Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection (NCT04381052) | Columbia University | 2020-05-18 |
| Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia (NCT04188405) | M.D. Anderson Cancer Center | 2020-05-17 |
| Prevention and Treatment of Pyrrolitinib-associated Diarrhea (NCT04736186) | Tianjin Medical University Cancer Institute and Hospital | 2020-05-16 |
| Baricitinib in Symptomatic Patients Infected by COVID-19: an Open-label, Pilot Study. (NCT04320277) | Hospital of Prato | 2020-05-16 |
| Allogenic Adipose Tissue-Derived Mesenchymal Progenitor Cells for the Treatment of Knee Osteoarthritis (NCT04208646) | Shanghai AbelZeta Ltd. | 2020-05-16 |